Gemma Hemmings
University of Leeds(GB)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Radiomics and Machine Learning in Medical Imaging, Cancer Treatment and Pharmacology, Medical Imaging Techniques and Applications, Gastric Cancer Management and Outcomes
Most-Cited Works
- → HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials(2015)234 cited
- → Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients WithRASWild-Type Advanced Colorectal Cancer(2016)111 cited
- → Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.(2011)78 cited
- → Intra-tumoral Heterogeneity ofKRASandBRAFMutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing(2011)70 cited
- → Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial(2015)26 cited
- KRAS and BRAF mutations in Nigerian colorectal cancers.(2014)
- → Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations(2017)24 cited
- → GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data(2023)24 cited
- → Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer(2023)19 cited
- → Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial(2024)19 cited